Oliver Lagore Vanvalin Investment Group Purchases 247 Shares of CVS Health Co. (NYSE:CVS)

Oliver Lagore Vanvalin Investment Group grew its position in shares of CVS Health Co. (NYSE:CVS) by 71.0% in the 2nd quarter, Holdings Channel reports. The firm owned 595 shares of the pharmacy operator’s stock after acquiring an additional 247 shares during the quarter. Oliver Lagore Vanvalin Investment Group’s holdings in CVS Health were worth $35,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Ables Iannone Moore & Associates Inc. bought a new position in CVS Health during the 4th quarter worth approximately $32,000. Creekmur Asset Management LLC bought a new stake in shares of CVS Health in the 4th quarter valued at $34,000. Steph & Co. increased its stake in shares of CVS Health by 192.0% in the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after acquiring an additional 288 shares in the last quarter. Kapitalo Investimentos Ltda bought a new stake in shares of CVS Health in the 4th quarter valued at $36,000. Finally, Scarborough Advisors LLC bought a new stake in shares of CVS Health in the 4th quarter valued at $37,000. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CVS. Evercore ISI lowered their price objective on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Barclays lowered their price objective on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, August 8th. Wells Fargo & Company boosted their price target on shares of CVS Health from $60.00 to $61.00 and gave the company an “equal weight” rating in a research note on Monday, August 12th. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Monday, September 16th. Eleven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $72.10.

CVS Health Trading Up 4.0 %

Shares of CVS opened at $61.38 on Friday. The business’s 50-day moving average price is $58.20 and its 200-day moving average price is $61.96. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25. The stock has a market cap of $77.05 billion, a PE ratio of 10.79, a P/E/G ratio of 0.81 and a beta of 0.53. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. CVS Health’s revenue for the quarter was up 2.6% compared to the same quarter last year. During the same period in the prior year, the business earned $2.21 earnings per share. On average, equities analysts forecast that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.33%. The ex-dividend date of this dividend is Monday, October 21st. CVS Health’s dividend payout ratio (DPR) is 46.75%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.